Lataa...
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance
BACKGROUND: Protein kinase CK2 inhibition has long been considered as an attractive anti-cancer strategy based on the following considerations: CK2 is a pro-survival kinase, it is frequently over-expressed in human tumours and its over-expression correlates with a worse prognosis. Preclinical eviden...
Tallennettuna:
| Julkaisussa: | Cell Oncol (Dordr) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Netherlands
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7717057/ https://ncbi.nlm.nih.gov/pubmed/33052585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13402-020-00566-w |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|